<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Sustiva; Efavirenz" /><meta name="IX" content="Sustiva; Efavirenz" /><title>Sustiva®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="78548.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="78548.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=78548.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2071.htm">5 Infections</a> &gt; <a href="3992.htm">5.3 Antiviral drugs</a> &gt; <a href="128394.htm">5.3.1 HIV infection</a> &gt; <a href="69472.htm">Non-nucleoside reverse transcriptase inhibitors</a> &gt; <a href="78513.htm">EFAVIRENZ</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="69472.htm" title="Previous: Non-nucleoside reverse transcriptase inhibitors">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="201547.htm" title="Next: ETRAVIRINE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a399004.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Efavirenz</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antivirals 8:18 &gt; Antiretrovirals 8:18.08 &gt; Nonnucleoside Reverse Transcriptase Inhibitors 8:18.08.16</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/3463-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Efavirenz</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: E &gt; Interactions of Efavirenz</p></div></li></ul><ul><li><h3>British National Formulary (3)</h3></li><li><a href="128394.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.1 HIV infection</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="200890.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Atripla®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; TENOFOVIR DISOPROXIL &gt; With efavirenz and emtricitabine</p></div></li><li><a href="78513.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">EFAVIRENZ</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Non-nucleoside reverse transcriptase inhibitors</p></div></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/129083.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.1 HIV infection</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/202112.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Atripla®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; TENOFOVIR DISOPROXIL &gt; With efavirenz and emtricitabine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/78513.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">EFAVIRENZ</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Non-nucleoside reverse transcriptase inhibitorsNon-nucleoside reverse transcriptase inhibitors</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22efavirenz%22%22efavirenz%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0620.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Efavirenz</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; E</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0005s0020.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Efavirenz</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; E</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/efavirenz_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) &gt; 231 Efavirenz</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/efavirenz_antimicrobial_efficacy.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial efficacy</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) &gt; 231 Efavirenz</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/efavirenz_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) &gt; 231 Efavirenz</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22efavirenz%22%22efavirenz%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/3463-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Efavirenz</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/03521.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Efavirenz</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; E &gt; EF</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E8E3E0R0D94.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Efavirenz</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; E</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c132.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Efavirenz</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; E</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_78513">EFAVIRENZ</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i874.htm" title="Go to appendix 1">Efavirenz</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">HIV infection in combination with other antiretroviral drugs</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">elderly; history
of mental illness or seizures; monitor liver function if receiving other
hepatotoxic drugs; <b>interactions: </b>Appendix
1 (<span>efavirenz</span>)</p><div class="cAV"><h3>Rash</h3> <p class="cAX">Rash, usually in the first 2 weeks, is the
most common side-effect; discontinue if severe rash with
blistering, desquamation, mucosal involvement or fever; if rash mild or moderate, may continue without interruption—usually
resolves within 1 month</p></div><div class="cAV"><h3>Psychiatric disorders</h3> <p class="cAX">Patients or
their carers should be advised to seek immediate medical attention
if symptoms such as severe depression, psychosis or suicidal ideation
occur</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">acute porphyria (but
see <a title="sub-section: Acute porphyrias" href="5181.htm#_5181">section 9.8.2</a>)</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">in mild liver disease, monitor for dose related side-effects
(e.g. CNS effects) and monitor liver function; avoid in moderate to
severe impairment; greater risk of hepatic side-effects in chronic
hepatitis B or C</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">manufacturer advises caution in severe renal failure—no
information available</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">manufacturer advises avoid (effective contraception
required during treatment and for 12 weeks after treatment); use efavirenz
only if no alternative available</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">see <a title="BNF:target-block: HIV infection-breast-feeding" href="128394.htm#_208142">Breast-feeding</a></p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">rash including Stevens-Johnson syndrome (see Rash
above); abdominal pain, diarrhoea, nausea, vomiting; anxiety, depression,
sleep disturbances, abnormal dreams, dizziness, headache, fatigue,
impaired concentration (administration at bedtime especially in first
2–4 weeks reduces CNS effects); pruritus; <i>less commonly</i> pancreatitis, hepatitis, flushing, psychosis, mania, suicidal ideation,
amnesia, ataxia, tremor, convulsions, gynaecomastia, blurred vision,
tinnitus; <i>rarely</i> hepatic failure, photosensitivity;
also reported raised serum cholesterol (see <a title="target-block: Lipodistrophy and HIV treatment" href="128394.htm#_128394.3">Lipodystrophy Syndrome</a>); see also <a title="target-block: Osteonecrosis and HIV treatment" href="128394.htm#_128394.5">Osteonecrosis</a></p></div><div class="cAF"><h2>Dose</h2> <p class="cR">See preparations below</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_78548" style="margin: 0 0 0 20px;"><h1 class="title">Sustiva®<span> (<a href="appendix-112803-B.htm#m45">Bristol-Myers Squibb</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Capsules, </span><span>efavirenz</span> 50 mg (yellow/white), net price 30-cap pack = £16.73; 100 mg (white),
30-cap pack = £33.41; 200 mg (yellow), 90-cap pack = £200.27. 
    Label:
    23<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF">600 mg once daily; <span class="cAK">child</span> 3–18 years see <a href="http://www.medicinescomplete.com/mc/bnfc/current/78513.htm" title="BNFC:monograph: EFAVIRENZ"><i>BNF for Children</i></a></p></div></div></div><div class="cAY"><span class="cAB">Tablets</span>, f/c, yellow, efavirenz
600 mg, net price 30-tab pack = £200.27. 
    Label:
    23<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF">600 mg once daily; <span class="cAK">child</span> body-weight over 40 kg see <a href="http://www.medicinescomplete.com/mc/bnfc/current/78513.htm" title="BNFC:monograph: EFAVIRENZ"><i>BNF for Children</i></a></p></div></div></div><div class="cAY"><span class="cAB">Oral solution,</span> sugar-free, strawberry
and mint flavour, efavirenz 30 mg/mL, net price 180-mL pack = £53.84<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF">720 mg once daily; <span class="cAK">child</span> 3–18 years see <a href="http://www.medicinescomplete.com/mc/bnfc/current/78513.htm" title="BNFC:monograph: EFAVIRENZ"><i>BNF for Children</i></a></p></div><div class="cAV"><h3>Note</h3> <p class="cAX">The bioavailability of <span class="cZ">Sustiva®</span> oral solution is lower than that of the capsules and tablets; the
oral solution is <b>not</b> interchangeable with either
capsules or tablets on a milligram-for-milligram basis </p></div></div></div></li><li><a href="200892.htm#_200892" title="With emtricitabine and tenofovir">With emtricitabine and tenofovir</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="69472.htm">Previous: Non-nucleoside reverse transcriptase inhibitors</a> | <a class="top" href="78548.htm#">Top</a> | <a accesskey="]" href="201547.htm">Next: ETRAVIRINE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>